Case Reports & Letters
26 March 2012
Vol. 4 No. 1 (2012)
https://doi.org/10.4081/rr.2012.e2

The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Behçet’s disease, inflammatory aortitis, infliximab, endovascular stenting
1155
Views
392
Downloads

Authors

Martin A. Lee
martinlee@doctors.org.uk
Rheumatology Department, National Hospital of Rheumatic Diseases, Bath, United Kingdom.
Stuart Kyle
Rheumatology Department, North Devon Hospital, Barnstaple, United Kingdom.
Robert J. Moots
Clinical Sciences Department, University Hospital Aintree, Liverpool, United Kingdom.
Behçet’s disease is a systemic vasculitis of unknown aetiology that may involve veins and arteries of all sizes. It occurs most commonly in the second or third decades of life and it is characterised by recurrent oral and genital ulceration and chronic relapsing uveitis. We present here a case of Behçet’s disease complicated by an inflammatory aortitis successfully treated with infliximab and endovascular stenting.

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



The successful treatment of inflammatory aortitis in Behçet’s disease with Infliximab and endovascular intra-aortic stenting. (2012). Rheumatology Reports, 4(1), e2. https://doi.org/10.4081/rr.2012.e2